TAO Synergies, previously known as Synaptogenix, a biotech firm, has announced the purchase of $10 million in Bittensor's TAO tokens, thereby becoming the largest publicly traded holder of the digital currency. The New York-based entity has acquired 29,899 TAO tokens at an average price of $334 per token, as stated in a press release. The plan is to stake these tokens within the Bittensor network, a platform that incentivizes participants for their contributions to the development of AI models.
According to Joshua Silverman, the company's executive chairman, the decision to invest in TAO rather than other popular cryptocurrencies for corporate treasuries is based on the anticipated continued growth and expansion of decentralized AI. While bitcoin and ether are the preferred choices for corporate treasuries, with publicly traded firms holding approximately 860,766 BTC and 1.8 million ETH, TAO Synergies is betting on the potential of decentralized AI. James Altucher, the company's treasury strategist, draws a parallel between decentralized AI and the internet in 1996, stating that although it's still early, growth is gaining momentum.
Following the announcement, TAOX shares experienced a 7.55% increase during Friday's trading session and an additional 1.29% rise in after-hours trading, reaching $10.24. Meanwhile, TAO tokens saw a 7% increase over the past week but dipped 2.5% in the last 24-hour period.